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ABSTRACT 
 
This study was designed to determine the safety of vertical whole-body vibration 
(WBV) by measuring effects on select muscle biochemical markers in yearling horses on 
stall rest. Twenty yearling horses (17 ± 2 mon) were randomly divided into a split plot 
experimental design consisting of treatment (n=10) and control (n= 10) groups. 
Horses were assigned uniform stalls by the Texas A&M University Horse Center 
and provided ad libitum access to water and trace mineral salt blocks. Horses were fed a 
diet for 100% of the NRC requirements for DE and 110% of the NRC requirements for 
protein, calcium, and phosphorus using 1.25% BW in Coastal Bermudagrass hay and 
0.75% BW in pelletized concentrate. 
The treatment group completed WBV on a vibration plate at 50 Hz 30 min per 
day 5 d per wk for 120 d. Serum was collected via jugular venipuncture in 6-mL lithium 
heparin tubes on D 0, 30, 60, and 120 before 30-min of turnout in on-site paddocks, and 
after turnout (control group only) or vibration (treatment group only). Only an initial 
blood draw was collected on Day 0 as a baseline value to serve as a covariate to which 
all mean values were adjusted. Samples were analyzed by Texas A&M University 
Veterinary Medical Teaching Hospital Clinical Pathology Lab for blood urea nitrogen 
(BUN), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), creatine 
kinase (CK), and lactic acid (LA) within 24 hr of collection. Statistical analysis was 
completed using the PROC MIXED procedure of SAS 9.4, and significance was set to P 
≤ 0.05. 
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There was no significant difference found serum BUN concentrations between 
the treatment and control groups across days and between pre- and post-treatment 
concentrations. No significant differences in serum AST and GGT concentrations were 
found between the experimental groups. Serum CK values were significantly different (P 
= 0.0277) between the treatment and control groups after treatment. There was no 
significant difference in serum LA concentrations between experimental groups. 
However, both groups each had a significant difference (P < 0.05) in LA values between 
D 30 and D 60 and between D 30 and D 120.  
Elevated serum CK and AST concentrations are indicative of muscle metabolism 
during work. The presence of LA in the blood is indicative of anaerobic metabolism 
after high intensity physical exercise. Serum GGT is a reliable biomarker used to 
differentiate between liver disease and healthy muscle metabolism when measured 
alongside CK concentration. Vertical WBV of young horses on stall rest has proven to 
be a safe therapeutic tool with little to no significant alterations in skeletal muscle 
biochemical markers over time. Further studies using uniform muscle biopsies and 
hourly blood collections post-vibration are recommended for further understanding of 
the potential therapeutic applications of WBV. 
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1. INTRODUCTION AND LITERATURE REVIEW  
 
1.1 Introduction 
Performance horses are equine athletes; they endure many methods of training in 
preparation for competition. Three-day eventing horses may have the most rigorous 
training regimen of all equine competitors: They require the endurance training for the 
cross-country event, high-intensity interval training (HIIT) to generate the power 
required for the over-fences event, and stamina for dressage. Racing Thoroughbred 
horses may require repeated bouts of short-distance (3/8 of a mile) at submaximal speeds 
with distance increasing over time. It is important to note that regardless of the training 
regimen, a horse will adapt to the training physically and physiologically. If training 
continues at submaximal potential (75-80% of maximum distance or speed) for a 
prolonged period of time, we begin to see signs of overtraining which could lead to 
breakdown of the athlete.  
Some of the most commonly reported musculoskeletal injuries to performance 
horses include trauma to supporting soft tissue structures such as the deep digital flexor 
tendon (DDFT) or the suspensory ligaments. These structures can require several months 
of strict stall rest and/or controlled exercise upon sustaining even a minor injury. Over-
exercising a horse can lead to joint inflammation (arthritis), inflammation of the synovial 
membrane within a synovial joint such as the knee (synovitis), cartilage breakdown, and 
chronic lameness. Overloading and overuse of muscles, tendons, and ligaments will lead 
to fatigue of these structures, significantly increasing the likelihood of injury. 
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1.2 Muscle Physiology  
 Skeletal muscles are connected to bones by tendons, which extend across a joint 
causing flexion or extension of a joint upon muscle contraction or relaxation. Skeletal 
muscles consist of hundreds of muscle fibers, each containing hundreds of myofibrils. 
However, the smallest functional unit of skeletal muscle is the sarcomere. A sarcomere 
is bordered on each end by Z discs, an A band that consists of thick and thin filaments, 
an I band at either end of the sarcomere, an M line and H zone at the center, and titin that 
connects thick filaments to the Z discs.  
Conscious muscle contraction is initiated by the central nervous system (CNS), 
which then transmits a signal called an action potential via the alpha and gamma motor 
neurons to the muscle spindle fibers. These neurons then release a neurotransmitter 
called acetylcholine from vesicles within the end of the neuron, which crosses the 
synaptic cleft to the motor end plate of a muscle that causes the calcium release from the 
sarcoplasmic reticulum for muscle fiber contraction. Upon muscle contraction, the Z 
discs get closer together, and I bands and H bands become smaller. For these changes to 
occur, calcium must be available for cross-bridge cycling to take place between the 
heads of the thick filaments made up of myosin and the thin filaments containing actin, 
troponin, and tropomyosin. Calcium released from stores within the muscle binds to 
troponin to pull the troponin-tropomyosin complex away from the myosin cross-bridge 
binding site on the actin. Once this site becomes available, the actin-binding site of the 
myosin head may attach to actin, which triggers what is called a “power stroke” that 
pulls the thin filament inwards towards the center of the sarcomere. At the end of the 
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power stroke, adenosine triphosphate (ATP) is required to allow myosin to detach from 
actin so that another power stroke may occur to pull the thin filament further inward. 
During this single described power stroke cycle, other myosin heads are binding to actin 
to undergo power strokes at different times and different rates so that the muscle 
contraction is continuous until the muscle is told to relax by the CNS and calcium is 
returned to storage or the muscle is depleted of energy resources (ATP, creatine 
phosphate, glycogen, etc.).  
Fiber types are differentiated by speed of contraction, time to fatigue, and 
metabolism. Type I fibers are referred to as slow-oxidative fibers; these fibers are 
responsible for slow, sustained contractions often found in postural muscles or 
endurance exercise muscles. Type I fibers contain low myosin-ATPase activity, but have 
high oxidative capacity which makes them highly resistant to fatigue. Long-distance 
runners or endurance racehorses have predominantly type I muscle fibers. Type IIa 
fibers are also oxidative fibers, but have a higher myosin-ATPase activity than type I 
fibers, which allows for faster contraction and lower resistance to fatigue. The last type 
of fiber is the type IIx fiber; this fiber type has the highest myosin-ATPase activity, 
lowest oxidative capacity, lowest resistance to fatigue, and fastest contraction speed of 
any of the fiber types. Type IIx fibers are glycolytic fibers and, therefore, contain a 
greater amount of glycogen than type I or type IIa fibers. Type IIx fibers are 
physiologically designed for high-intensity physical exertion. Olympic weightlifters and 
racing Quarter horses have a high percentage of type IIx fibers.  
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 Beginning at birth and lasting through their first year of life, horses experience an 
increase in muscle length and cross-sectional area due to the insertion of new sarcomeres 
to myofibrils at either end of the muscle which is stimulated by the presence of growth 
hormone (GH), insulin, and thyroid hormone. In order for muscles to grow or increase in 
volume, they must increase in diameter of their fibers or undergo hypertrophy at the 
level of the myofibril or by increasing glycogen stores. Hypertrophy is the result of 
increased protein synthesis, satellite cell activation, or post-exercise micro-tears. 
Isometric contractions (muscle stretching), in addition to the presence of testosterone, 
induce splitting at the Z-discs of the sarcomere, leading to increased fiber diameter. 
Satellite cells are undifferentiated muscle stem cells that are activated by cytokines and 
growth factors, such as insulin-like growth factor-1 (IGF) and fibroblast growth factor-2 
(FGF). IGF-I is responsible for both proliferation and differentiation of satellite cells, 
whereas FGF-2 stimulates satellite cell proliferation only (La Vigne et al, 2015). 
Muscle atrophy is muscle wastage, reduction in muscle size, and reduced ability 
to generate force (Berg et al., 1997) that can occur upon incursion of a traumatic injury 
that causes denervation of muscle or any number of conditions or injuries that leads to 
disuse of a muscle or muscle group. Also, muscle dystrophy is a genetic disease that also 
leads to whole body muscle atrophy in addition to concurrent medical conditions. Disuse 
atrophy is most commonly seen in hospital patients on prolonged bed rest after a surgical 
operation or hospitalization for other health complications. In human models, prolonged 
disuse of muscle can result in substantial loss of muscle mass, strength, and 
circumference (Narici and de Boer, 2011). Ferrando et al. (1995) found human subjects 
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on a strict bed rest regimen for a period of 7 days lost at least 3% of thigh volume. Berg 
et al. (1997) found that human ICU patients on bed rest for 6 weeks experienced a 14 ± 
4% reduction and 13 ± 9% reduction in the cross-sectional area and maximum torque 
production of the knee extensor muscle, respectively. Additionally, the previous study 
concluded that the loss of cross-sectional area and torque producing ability is not the 
result of muscle fiber type alterations. Kawahara et al. (2017) found that patients 
admitted to the ICU that were placed on bed rest for 72 h did not experience significant 
changes in limb circumference, however there was a significant decrease in limb 
circumference at 144 h post-admission with the greatest circumference reduction 
occurring in the lower limbs. 
1.3 Muscle Adaptations With Age and Training 
 From birth, young horses will experience little or no change in oxidative capacity 
until they reach one year of age. Standardbred foals show a decrease in glycolytic 
capacity as they age, whereas Thoroughbred foals experience an increase in glycolytic 
capacity. Thoroughbred foals have greater alterations in their type IIa and IIx fiber ratios 
while their type I fibers remain unchanged. Overall, foals increase the ratio of type I and 
IIa:type IIx fibers during their first year of life. Alterations in oxidative and glycolytic 
capacity in addition to fiber composition are related to an increase in coordination, 
increase in proprioception, breed, gender, and genetics.  
 As training begins near their second year of life, young horses begin to see an 
increase in the type IIa to IIx fiber ratio, with a 30-70% increase in fiber size. However, 
Thoroughbred yearlings will have an increase in fiber size leading up to the 
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commencement of training as a result of aging. Unsurprisingly, aerobic training for 
endurance horses or long-distance race horses does not induce a profound increase in 
fiber area because aerobic training stimulates an increase in the type IIa:IIx fiber ratio 
and type IIa fibers have a smaller cross-sectional area. This reapportionment of fiber 
distribution is valuable in low-intensity, long-duration physical activity because a 
smaller cross-sectional area allows for more rapid oxygen transport through working 
muscle along with faster waste product removal from the same tissue.  
 Improved oxidative capacity effectively improves performance by making ATP 
formation more efficient, improving buffering capacity of lactate accretion, and allowing 
for improved free fatty acid oxidation to spare glycogen stores. The commencement of 
training increases the oxidative enzyme activity of skeletal muscle two-fold in addition 
to increasing the number of high-oxidative fibers and overall oxidative capacity within 
the first few months of training. However, glycolytic enzymes remain unaltered during 
training. Lactic acid dehydrogenase (LDH) is unlike other glycolytic enzyme activities 
in that its activity decreases with training, possibly due to improved static and dynamic 
buffering mechanisms within the muscle. Also, more high-oxidative type IIa fibers will 
convert to type IIx fibers with training.  Creatine kinase (CK), phosphofructokinase 
(PFK), and LDH activity increase with intensive anaerobic training regimens.  
1.4 Biochemical Markers 
 Several serum biochemical markers have been evaluated for efficacy in 
determining health status of the body. Creatine kinase (CK), lactate dehydrogenase 
(LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-
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glutamyltransferase (GGT) are the enzymes responsible for differentiating between 
muscle damage due to myopathies and exercise or liver damage. Blood urea nitrogen 
(BUN) is also a valuable blood marker used to evaluate the degree to which proteins are 
broken down in the body to produce urea via catabolic pathways or measure the degree 
of dehydration (hypovolemia). Recent studies have shown that female horses experience 
an increase in BUN, CK, and LDH post-exercise where male horses do not; however, 
both genders show an increase in AST and GGT post-exercise (Di Filippo et al., 2016).  
 Measuring BUN before and after physical exertion is a method for evaluating the 
kidney’s ability to efficiently eliminate urea that is produced by the degradation of 
muscle protein during exercise. This test is popular among small animal veterinarians 
and human physicians to exclude the kidneys as a possible source of complication.  
 Creatine kinase (CK) is an enzyme found in the mitochondria and cytosol of cells 
in multiple forms. CK is responsible for the conversion of adenosine triphosphate (ATP) 
to adenosine diphosphate (ADP) by the transfer of one phosphate group to creatine to 
synthesize phosphocreatine. This reversible pathway forms a more stable energy reserve 
during muscle contraction (Brancaccio et al., 2010). During muscle contraction, CK is 
responsible for the conversion of creatine phosphate and ADP to creatine and ATP to 
fuel muscle contraction. Researchers have found that an increase in CK in response to 
exercise is highest after intense, endurance exercise; however, weight-bearing exercise 
proves to have a greater increase from baseline in enzyme activities. Trained human 
athletes experience less of an increase in CK when compared to untrained individuals, 
which suggests an adaptive response of the body’s enzymatic release to exercise 
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(Horobagyi and Denhan, 1989). However, Koutedakis et al. (1993) found that the 
duration of physical exertion rather than physical fitness level of the individual had a 
stronger relationship to serum CK, AST, and ALT activities.  
 Lactate dehydrogenase (LDH) is the enzyme responsible for the conversion of 
lactate to pyruvate and vice versa while also reducing NAD+ to NADH in nearly all 
cells. Under anaerobic conditions, LDH favors the conversion of pyruvate to lactate in 
muscle cells after glycolysis. During the Cori cycle in the liver, LDH converts lactate to 
pyruvate, an energetically unfavorable reaction. Kobayashi et al. (2005) concluded that 
endurance exercise activities lead to a 100% increase in serum LDH activity, and levels 
remained elevated for approximately 2 wk post-exercise. In summary, muscle LDH 
response is correlated with muscle fiber composition (Costill et al., 1976).  
 Aspartate aminotransferase (AST) is the enzyme responsible for the conversion 
between aspartate and α-ketoglutarate to oxaloacetate and glutamate, which occurs 
between the mitochondria and the cytosol to form energy by transamination. Though this 
process produces viable energy for the cell, both its reactants and products are substrates 
for the tricarboxylic acid cycle, an aerobic energy-forming pathway within 
mitochondria. AST is primarily found in the cardiac and skeletal muscle cells, liver, and 
red blood cells. This enzyme is particularly useful in differentiating between healthy 
muscle activity and liver disease. An immediate increase in AST activity lasting for 
approximately 24 h after physical activity proportionate to the duration of the activity 
has been reported in previous research conducted by Lippi et al. (2008). 
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 Gamma-glutamyltransferase (GGT) is an enzyme produced most notably in the 
liver, but it has been found in numerous other tissues as well. GGT is responsible for the 
conversion of amino acids, peptides, and water to glutathione by transfer of a gamma-
glutamyl group. Physiological GGT levels are observed in the presence of elevated CK 
values in Duchenne muscular dystrophy patients, indicating the presence of a muscular 
disorder in the absence of liver disease and confirming the viability of GGT in 
distinguishing liver and muscle disease while CK is elevated (Rosales et al., 2008).  
 The aforementioned metabolites and enzymes, which represent some of the most 
valuable biochemical markers involved in the identification and differentiation of muscle 
degradation, were used in this study.  
1.5 Whole-Body Vibration Treatment 
 Human medicine adopted therapeutic vibration plates long before the equine 
world; however, researchers have had limited results with the vibration plates. A study 
conducted in 2017 found only that the therapy method is safe and observed an increase 
in metabolism for patients on bed rest in intensive care units (Wollersheim et al., 2017). 
Early studies evaluating the effects of WBV in horses sought only to determine the 
physiological response of the musculoskeletal system after low-intensity vibration by 
measuring vitals, CK, cortisol, osteocalcin (OC), creatinine, myeloperoxidase activity 
(MPOa), and other biological indicators of muscle and bone metabolism (Carstanjen et 
al., 2013). Buchner et al. (2016) employed electromyography to measure muscle 
vibration and activity during whole-body horizontal vibration for a single bout of 10 
min; these researchers did not observe any additional EMG activity while the horses 
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were on the plate, and deemed WBV an inadequate warm-up and exercise. A study 
evaluating the possibility of a vibration plate for therapeutic purposes in lame horses 
found no statistically significant improvements or alterations in the lameness status of 
horses undergoing treatment for 30 min twice per day, 5 d per wk for 60 d (Halsberghe, 
2017). Neither Carstanjen et al. (2013) nor Buchner et al. (2016) employed a single 
uniform frequency of vibration for their studies.  
Further investigation is necessary to determine the long-term alterations in serum 
biomarkers of muscle metabolism with a greater experimental population than in 
previous research studies. Furthermore, evaluation of the effects of vertical WBV for a 
greater duration of time per session and at a higher uniform frequency could provide 
insight into the effects of WBV as an alternative form of controlled exercise for injured 
horses on strict stall rest.  
1.6 Goals and Objectives 
The objectives of this study are to measure the changes in the serum 
concentrations over the course of the study as well as before and after treatment of the 
two experimental groups of the following biochemical markers: 
1. Blood urea nitrogen (BUN) 
2. Aspartate aminotransferase (AST) 
3. Gamma-glutamyltransferase (GGT) 
4. Creatine kinase (CK) 
5. Lactic acid (LA) 
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The concentrations of these biomarkers were used to evaluate changes in skeletal 
muscle metabolism in order to determine relative safety of vertical WBV on skeletal 
muscle in yearling horses. 
 This study was a companion study conducted alongside researchers evaluating 
the effects of vertical WBV on bone density and turnover in yearling horses on stall rest.  
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2. PROBLEM 
 
2.1 Muscle Atrophy 
Prolonged muscle disuse due to traumatic muscle or nerve injury or reduced, 
restricted, or absent physical exertion leads to reduced muscle volume, circumference, 
and mass, otherwise described as muscle atrophy. During a period of prolonged disuse, 
the body will choose to reapportion energy that would normally be designated for the 
tissue structure(s) no longer in use to more energetically demanding structures or store 
excess energy in various forms.  In the case of injured horses on stall rest, restricted 
movement is necessary for healing and prevention of further trauma or pain, however 
limiting the movement of the horse prevents muscle growth and allows the body to 
determine that certain muscle fibers, primarily type IIx fibers as they are the most 
energetically demanding, no longer require the same amount energy resources for 
maintenance. As long as muscles are not being used they will continue to decrease in 
size, mass, circumference, and maximum strength (Berg et al., 1997). Once a horse has 
completed its required stall confinement period, gradual reintroduction to physical 
exercise is necessary to prevent re-injury due to weak connective soft tissue structures 
and weakened skeletal muscles.  
2.2 Owner Investment 
 From the moment of injury through treatment and rehabilitation, horse owners 
limit their horses’ physical movement and stress to prevent further damage to the already 
injured structures. By confining their horses and preventing their use, horse owners 
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begin to invest more money in their care with less return on their investment. Veterinary 
diagnosis and treatment, feed bills, boarding, medications, possible surgical intervention, 
and treatment supplies (bandaging materials, salves, etc.) all require substantial 
monetary investment and time by way of the owner. Also during this time, the horse is 
not in training or competing, and, therefore, losing value. If the horse goes back to 
training or on to compete after injury and recovery, the risk of injuring the same 
structure or supporting structures is much higher. In addition, if the horse is placed on 
the market in the future, responsible buyers will have an equine veterinarian complete 
radiographs of vital structures (the spine, hocks, forelegs, etc.) to identify any prior 
injuries that the current owner has left undisclosed; identification of previously damaged 
musculoskeletal structures decreases the value of the horse due to the assumption that 
the injury may reoccur and require further investment for treatment and rehabilitation.  
 In the Thoroughbred racing industry, time that a horse spends not in training due 
to injury or any other medical complication is referred to as “wastage” (Bailey et al., 
1997). Wastage encompasses financial and physiological variables, including money 
spent on treatment and rehabilitation and money lost by having to scratch a horse from a 
race with a large purse.  
 In summary, as long as the horse remains on stall rest unable to work, the owner 
is investing more money in the care and treatment of the animal to ensure its full 
recovery than the owner is receiving from the animal.  
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2.3 Animal Health and Welfare 
While an injured horse is kept on strict stall confinement with or without 
restricted exercise, it is important that the horse is still allowed to exhibit natural equine 
behavior both inside and outside the confines of their stall to relieve stress and anxiety 
that can reduce the rate of healing. By reducing the rate of healing, the duration of 
confinement is extended and the horse is subjected to continued stress, forming a 
continuous cycle.  
 Injury and stall rest inhibit a horse’s ability to exhibit natural behavior, allow for 
increasing stress and discomfort associated with the inability to express natural behavior, 
which prolongs the exposure to pain due to injury. These characteristics of stall 
confinement, even if it is for the horse’s well-being, violates three of the Five Freedoms 
proposed by the United Kingdom’s Farm Animal Welfare council in 1965 (Farm Animal 
Welfare Council, 2009). The Five Freedoms include: 
1. Freedom from hunger or thirst 
2. Freedom from discomfort 
3. Freedom from pain, injury, or disease 
4. Freedom from fear and distress, and  
5. Freedom to express natural behavior.  
By allowing for the cycle of limited exercise of natural behavior, increased stress, and 
prolonged pain to continue, horse owners are not attending to the overall welfare of the 
animal to the best of their abilities.  
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 It is also important that we evaluate the safety of therapeutic tools such as the 
whole-body vibration plate for horses, young and old alike. Determining the safety of 
these devices for skeletal muscle and full-body health is an important factor in overall 
equine welfare.  
2.4 Problem Summary 
 Researchers, veterinarians, and professionals in the equine industry are still 
seeking the most effective and efficient method to reduce time spent on stall rest, reduce 
financial instability and improve animal health and wellbeing during the healing process.  
 It is because of these tribulations in combination with promising human studies 
that equine professionals have embraced vertical WBV as a viable form of rehabilitation 
and physical therapy without concrete proof of its efficacy in equine models. In this 
study, we seek to answer the question of whether or not vertical WBV is a safe 
therapeutic tool for growing horses on extended stall rest by evaluating skeletal muscle 
biochemical markers that may indicate muscle damage. 
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3. MATERIALS AND METHODS 
 
3.1 Experimental Design  
Twenty horses 17±2 mon of age consisting of 16 mares and 4 geldings were 
selected from the horse herd owned by Texas A&M University’s Animal Science 
Department and leased from private owners. All horses were of Quarter Horse or stock 
horse breeds. All horses were thoroughly evaluated by a veterinarian from Texas A&M 
University for overall health status prior to the onset of the study. Horses were 
maintained under the approval of the Texas A&M University Institutional Animal Care 
and Use Committee (AUP 2016-0090; appendix A) by the author, assisting researchers, 
Texas A&M University Horse Center staff, and undergraduate student assistants. 
All horses were housed in 43.9 m2 (3.66 m x 3.66 m) stalls at the Dick Freeman 
Arena, and were allowed 3 to 5 d for acclimation prior to the commencement of the 
study. Stalls were cleaned every morning as the horses were turned out or being 
vibrated. On weekends, horses remained in their stalls. Horses were turned out two at a 
time to on-site individual paddocks.  
All horses were provided ad libitum access to water and trace mineral salt blocks 
for the duration of the study. Horses were fed a diet at 100% of the NRC 
recommendations for DE and 110% of the NRC recommendations for calcium, 
phosphorus, and protein for 120 d using Coastal Bermudagrass hay and pelletized 
concentrate (Producer’s Cooperative, Bryan, Texas).  
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Horses were randomly and evenly assigned to one of two groups. The treatment 
group (n=10) stood on a vertical whole-body vibration (WBV) plate provided by 
Equivibe (Lincoln, NE) for 30 min per day 5 d per wk (Monday-Friday) with the 
vibration frequency set to 50 Hz. Horses in the control group (n=10) were returned to 
their stalls after turnout.   
Each horse was weighed on a calibrated scale on D 0, 30, 60, 90, and 120, and 
individual weight measurements in pounds were recorded to ensure positive growth. 
Blood samples were collected on D 0 (before turnout) and D 30, 60, and 120 pre- and 
post-turnout (control group only) to vibration (treatment group only). The D 0 collection 
taken prior to turnout served as the baseline values for which all sample means were 
adjusted to as a covariate during statistical analysis. Serum samples were collected via 
aseptic jugular venipuncture using a 20 g hypodermic needle into a 6-mL lithium-
heparin test tube, which was inverted 8 times prior to placement in a cooler with ice. 
Once all samples were collected, they were transported to the Texas A&M University 
Veterinary Medical Teaching Hospital’s Clinical Pathology Laboratory for analysis 
within 24 h of collection.  All blood samples were evaluated for creatine kinase (CK), 
gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST), lactic acid (LA), 
and blood urea nitrogen concentrations (BUN).  
3.2 Data Analysis 
The model was evaluated as a repeated measures or split plot design. Mixed 
model analysis was completed using the PROC MIXED procedure of SAS 9.4 (SAS, 
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INC., 2014), and significance was set to P ≤	0.05. SAS was used to determine the 
interactions, if any, between treatment, time, and day of each biomarker measured. 
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4. RESULTS 
 
Table 1. Summary of Treatment Effect of WBV on Select Biochemical Markers. 
 
 
 
 
                                                
1 Biochemical markers: Blood urea nitrogen, BUN; aspartate aminotransferase, AST; 
gamma-glutamyltransferase, GGT; creatine kinase, CK; lactic acid, LA.  
 
 
Serum BUN concentration had significant day (P < 0.0001) and time (P = 
0.0172) interactions with no treatment effect (Figure 1). The figure also elucidates the 
significant quadratic effect of day for BUN concentrations over the course of the study. 
 
 Day 0 Day 30 Day 60 Day 120 SE 
Biochemical 
Marker1 
Before 
Only 
Before After Before  After Before After   
BUN (mg/dl) 16.00 13.66 13.82 12.67 12.37 16.27 15.42 0.34 
AST (U/L) 347.80 293.90 292.6 302.65 302.45 308.85 292.45 9.08 
GGT (U/L) 24.45 21.91 21.96 21.66 20.51 21.40 20.10 0.46 
CK (U/L) 209.95 186.13 228.39 168.15 224.42 190.73 198.92 15.51 
LA (mg/dl) 7.62 10.63 9.61 8.01 7.70 7.99 7.57 0.36 
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Figure 1. Effects of Treatment on BUN Over Time. (“Con”= control group, “Trt”= 
treatment group, “A”= before treatment, “B”= after treatment). 
 
 
Average serum BUN concentration decreased for both the treatment and control 
groups from an average of 14.21 ± 0.26 mg/dl before turnout to 13.87 ± 0.26 mg/dl after 
completing treatment. However, no significant difference was found in serum BUN 
concentrations between the groups before and after treatment. Only a significant 
difference (P = 0.0404) was observed in horses of the treatment group before and after 
treatment. Additionally, serum BUN concentration increased in a quadratic trend for 
both experimental groups beginning at 13.76 ± 0.31 mg/dl on D 30, 12.52 ± 0.31 mg/dl 
on D 60, to 15.84 ± 0.31 mg/dl by D 120. No significant difference was observed 
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between the treatment and control groups for the duration of the project. The results 
show a significant difference (P < 0.05) between each day for each group.  
Serum AST concentration had a significant interaction with time (P = 0.0438) in 
addition to a significant treatment-time interaction (P = 0.0110). The control group 
experienced a mild but not significant decrease in average AST values from 301.22 ± 
7.41 U/L before to 287.69 ± 7.41 U/L after turnout over the entirety of the study, and 
horses within the treatment group did not experience a significant change in serum AST 
values (Figure 2).  
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Figure 2. Effects of Treatment on AST Over Time. (“Con”= control group, “Trt”= 
treatment group, “A”= before treatment, “B”= after treatment). 
  
 
The AST values of the horses within the treatment group averaged 302.38 ± 7.41 
U/L prior to turnout and 303.98 ± 7.41 U/L after vibration. No significant difference was 
found in serum AST concentration between or within either experimental group before 
and after treatment. 
Serum GGT concentrations revealed a significant interaction with time (P = 
0.0331) in addition to a significant linear effect over the course of the study. However, 
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only the control group had a significant alteration (P = 0.0161) in serum GGT 
concentration before and after treatment. Additionally, there was a significant treatment-
time interaction (P = 0.0349) without any significant alterations in serum GGT 
concentrations between the treatment and control groups (Figure 3).  
 
 
 
Figure 3. Effects of Treatment on GGT Over Time. (“Con”= control group, “Trt”= 
treatment group, “A”= before treatment, “B”= after treatment). 
 
 
Horses in the control group had a greater reduction in serum GGT values 
compared to the treatment group from before to after treatment. Control horses averaged 
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21.84 ± 0 .37 U/L before turnout and 20.57 ± 0.37 U/L after turnout, whereas treatment 
horses averaged 21.47±0.37 U/L before turnout and 21.14 ± 0.37 U/L after vibration.  
Serum CK concentration had a statistically significant treatment-day interaction 
(P = 0.0176) in addition to a significant interaction with time (P = 0.0012). A statistically 
significant difference (P = 0.0277) between the control and treatment groups was found 
in post-treatment serum CK concentrations in addition to the concentrations for the 
treatment group before and after treatment (P = 0.0034). Horses in the treatment group 
had increased serum CK concentrations (average of before and after treatment 
concentrations) from 194.91 ± 14.36 U/L on D 30 to 209.73 ± 14.35 U/L by D 120 while 
the horses in the control group experienced a decrease in serum CK concentrations from 
219.60  ± 14.35 U/L on D 30 to 179.92 ± 14.36 U/L by D 120. However, the difference 
in serum CK concentrations between experimental groups pre- and post-treatment is not 
significant. Figure 4 demonstrates the effects of treatment, day, and time on serum CK 
concentrations.   
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Figure 4. Effects of Treatment on CK Over Time. (“Con”= control group, “Trt”= 
treatment group, “A”= before treatment, “B”= after treatment). 
 
 
Type 3 tests for fixed effects revealed both day (P < 0.0001) and time 
interactions (P = 0.0147) for serum LA concentration (Figure 5). No significant 
difference was found between the control and treatment groups between each collection 
day. However, significant differences (P < 0.05) were found for each experimental group 
from D 30 to D 60 and D 30 to D 120 only. Additionally, Figure 4 depicts the significant 
quadratic effect of day on serum LA concentrations.  
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Figure 5. Effects of Treatment on LA Over Time. (“Con”= control group, “Trt”= 
treatment group, “A”= before treatment, “B”= after treatment). 
 
 
No significant difference was found between experimental groups before and 
after treatment. However, there was a significant difference (P = 0.0297) for the only the 
treatment group before and after treatment. The control group experienced a decrease in 
serum LA concentration after treatment each day except for D 120. The serum LA 
concentration for the horses in the treatment group decreased each collection day. 
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Table 2. Summary of Day Effect of WBV on Select Biochemical Markers. 
Biochemical 
Marker Day 0 Day 30 Day 60 Day 120 Std Error 
BUN (mg/dl) 16.00 13.76a 12.52a 15.84a 0.31 
AST (U/L) 347.80 293.25 302.55 300.65 6.42 
GGT (U/L) 24.45 21.93 21.08 20.75 0.33 
CK (U/L) 209.95 207.26 196.29 194.82 11.01 
LA (mg/dl) 7.62 10.12bc 7.86b 7.78c 0.25abc 
                                                
abc Superscripts of the same letter indicate a statistically significant difference (P < 0.05) 
between two values. 
 
 
 
Tables 3 and 4 describe the complete nutritional analysis of the Coastal 
Bermudagrass hay provided to the horses at the beginning of the study and the end of the 
study for comparison. The initial analysis was completed May 4, 2016. The final hay 
analysis was completed on September 16, 2016. 
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Table 3. Initial Coastal Bermudagrass Hay Nutritional Analysis.
Components3 As Fed DM 
% Moisture 7.30 - 
% Dry Matter 92.70 - 
% Crude Protein 9.90 10.70 
% Adjusted Crude 
Protein 9.90 10.70 
% ADF 39.40 42.50 
% aNDF 69.50 75.00 
% NFC 4.70 5.10 
% TDN 51.00 55.00 
NEL, Mcal/lb 0.34 0.36 
NEM, Mcal/lb 0.42 0.46 
NEG, Mcal/lb 0.19 0.21 
Relative Feed Value - 69.00 
% Calcium 0.35 0.37 
% Phosphorus  0.20 0.21 
% Magnesium 0.16 0.18 
% Potassium 0.65 0.70 
% Sodium 0.37 0.39 
PPM Iron 228.00 246.00 
PPM Zinc 20.00 21.00 
PPM Copper 6.00 7.00 
PPM Manganese 238.00 257.00 
PPM Molybdenum  0.60 0.60 
Horse DE, Mcal/lb 0.74 0.80 
                                                
3 Components: Acid detergent fiber, ADF; neutral detergent fiber, aNDF; non-fibrous 
carbohydrate, NFC; total dietary nitrogen, TDN; net energy for lactation, NEL; net 
energy for maintenance, NEM; net energy for gain, NEG. Coastal Bermudagrass hay 
sample submitted for analysis May 4, 2016. 
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Table 4. Final Coastal Bermudagrass Hay Nutritional Analysis. 
Components As Fed DM 
% Moisture 8.00 - 
% Dry Matter 92.00 - 
% Crude Protein 14.00 15.20 
% Adjusted Crude 
Protein 14.00 15.20 
% ADF 32.20 34.90 
% aNDF 62.50 67.90 
% NFC 7.10 7.70 
% TDN 52.00 57.00 
NEL, Mcal/lb 0.42 0.46 
NEM, Mcal/lb 0.45 0.49 
NEG, Mcal/lb 0.22 0.24 
Relative Feed Value - 85.00 
% Calcium 0.35 0.38 
% Phosphorus  0.20 0.21 
% Magnesium 0.18 0.2 
% Potassium 0.69 0.75 
% Sodium 0.46 0.50 
PPM Iron 207.00 225.00 
PPM Zinc 26.00 28.00 
PPM Copper 11.00 12.00 
PPM Manganese 170.00 184.00 
PPM Molybdenum  0.40 0.50 
Horse DE, Mcal/lb 0.81 0.884 
                                                
4 Complete feed analysis for Coastal Bermudagrass hay submitted September 16, 2016. 
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5. DISCUSSION 
 
Serum BUN is a measurement of the body’s degradation of muscle protein 
during exercise and an indicator of kidney function. According to these results, WBV 
did not have a significant effect on BUN values between the treatment and control 
groups. However, the day of serum sample collection and the time at which the sample 
was taken each had significant effects on the measured serum BUN concentrations of 
both groups. The decline of this value after physical exercise indicates the absence of 
protein degradation or muscle breakdown in addition to healthy kidney function, which 
suggests that vertical WBV is not physically intense enough to produce detrimental 
skeletal muscle damage.  
According to Lippi et al. (2008), serum AST increases in proportion to the 
duration of exercise. In this study, both the control and treatment horses had an overall 
decrease in AST values from before turnout to after turnout or vibration, respectively. 
However, the treatment-time interaction reported in the results indicates that the control 
group had a greater overall decline in average AST values after turnout compared to the 
treatment group. The absence of significant differences in serum AST concentrations 
suggests that neither turnout nor vertical WBV was intense enough or long enough to 
substantially increase AST values.  
 Elevated serum GGT is an indicator of liver disease only when combined with 
elevated serum CK. Both the treatment group and the control group experienced a 
decline in GGT in addition to a concurrent increase in CK values from before turnout to 
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after turnout or vibration. The control group had a greater decline in serum GGT values 
compared with the treatment group from before turnout to after treatment. The treatment 
group experienced a safe increase in serum CK concentration while the control group 
had an overall decrease in serum CK from D 30 to D 120. Elevated serum CK values are 
indicative of anaerobic activity. The reduced GGT values combined with elevated CK 
values indicate normal, healthy muscle and enzymatic activity in the absence of liver 
disease, supporting the hypothesis that vertical WBV is a safe therapeutic method for 
horses. 
 The presence of elevated blood lactic acid (LA) or lactate after physical activity 
is a strong indication that anaerobic metabolism has recently taken place. Both the 
control and treatment groups experienced a decrease in serum LA concentration, 
demonstrating the absence of physical exercise intense enough to overwhelm the body’s 
natural ability to buffer any LA produced during turnout or vibration treatment. This 
could mean the vibration treatment was not of significant intensity in vibration plate 
frequency, long enough in duration on the plate, extensive enough in duration of the 
study, or simply ineffective as a method of anaerobic exercise.  
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6. CONCLUSION 
 
Horse owners and riders are continuously looking for the most effective, 
efficient, and financially reasonable injury prevention and rehabilitation techniques. 
Unfortunately, not all of the methods and techniques the horse industry employs are 
proven effective for the designated purpose until long after they have gained infamy. 
In the case of the whole-body vibration plate as a tool for warm up exercise, physical 
therapy, rehabilitation, and treatment, previous research studies have found no evidence 
that suggests it is a viable tool for these purposes. In this study, we employed similar 
methods for measuring and testing the safety of vertical WBV as a therapeutic tool in 
addition to evaluating any changes in skeletal muscle biochemical markers for 
metabolism. Based on the results of the biochemical markers, in terms of muscle 
metabolism, vertical WBV is a safe therapeutic tool for growing, healthy horses. There 
is no evidence to suggest it may cause detrimental skeletal muscle damage based on the 
biochemical markers that were analyzed. Therefore, WBV can be considered a safe 
therapeutic tool for young horses.  
Further research into this method of therapy may not be necessary. However, 
future studies should consider uniform muscle biopsy to monitor alterations in muscle 
fiber composition during periods of stall rest and vibration therapy. Evaluating heart 
rate, serum glucose and cortisol, and other valuable oxidative and glycolytic enzyme 
activities before, during, and after could add valuable insight to future academic studies 
on WBV in growing and mature equines both injured and healthy. 
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IACUC AUP #: 2016-0090 
 
DIVISION OF RESEARCH
Research Compliance and Biosafety
750 Agronomy Road, Suite 2701  
1186 TAMU  
College Station, TX 77843-1186
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ALRSRCH - Agrilife Research - Animal Science
FROM: Dr. John N. Stallone, Chair 
Institutional Animal Care and Use Committee 
SUBJECT: Approval of Amendment  
AUP: IACUC 2016-0090
Title: The Effect of Vertical Whole Body Vibration on Bone Density in Horses. 
Reference Number: 040293
AUP Approval Date: 05/19/2016
     Expiration Date: 05/18/2019
Species: Equine
This is to inform you that the IACUC has approved the above-referenced amendment as follows:
• Caitlyn Hyatt has been added to this study.
The Committee thanks you for your efforts to keep the IACUC informed of any changes to your 
protocol. If we can be of any further assistance, please contact the IACUC office at 979.845.1828.
Best of success in your research endeavors.
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APPENDIX B 
 
 
96/1012 
14% HORSE PELLET 
For Foals, Mares and Mature Working Horses 
GUARANTEED ANALYSIS 
Crude Protein  (Min) 14.00 % Phosphorus  (Min) 0.50 % 
Crude Fat  (Min) 6.00 % Copper  (Min) 45 PPM 
Crude Fiber  (Max) 10.00 % Selenium  (Min) 0.3 PPM 
Calcium  (Min) 0.60 % Zinc  (Min) 110 PPM 
Calcium  (Max) 1.00 % Vitamin A  (Min) 2,500 IU/LB 
INGREDIENTS 
Grain Products, Processed Grain Byproducts, Forage Products, Roughage Products (8%), Soybean Meal, Soybean 
Oil, Molasses Products, Ground Limestone, Monocalcium Phosphate, Salt, Vitamin A Supplement, Vitamin D3 
Supplement, Vitamin E Supplement, Vitamin B12 Supplement, Riboflavin Supplement, Niacin Supplement, Calcium 
Pantothenate, Menadione Sodium Bisulfite Complex, Folic Acid, Biotin, Thiamine Mononitrate, Pyridoxine 
Hydrochloride, L-Ascorbyl-2-Polyphosphate, Selenium Yeast, Cobalt Carbonate, Ferrous Sulfate, Ethylenediamine 
Dihydriodide, Manganese Sulfate, Zinc Sulfate, Copper Sulfate, Calcium Carbonate, Mineral Oil, Yeast Culture, Zinc 
Proteinate, Manganese Proteinate, Copper Proteinate, Dried Yeast Fermentation Solubles, Cobalt Proteinate, 
Brewers Dried Yeast, Dried Saccharomyces Cerevisiae Fermentation Solubles, Hydrated Sodium Calcium 
Aluminosilicate, Silicon Dioxide, Yucca Shidigera Extract, Calcium Propionate and L-Lysine. 
FEEDING DIRECTIONS 
Use the following table as a guide for the amount of feed to be fed per 100 pounds of bodyweight, according to 
designated horse type.  Adjustments in these amounts should be based upon the quality of the forage (hay and/or 
pasture) the horse is consuming, size of the horse, and its degree of activity. 
 
Horse Type Daily Amt./ 
 100 lbs. Bodyweight 
Mature Working Horse 0.5 to 1.25 lbs. 
Lactating Mare 1 to 2 lbs. 
Growing Horse 1 to 3 lbs. 
 
In order to reduce the risk of colic, always feed at least 1-2 pounds of hay or forage per 100 pounds of bodyweight.  
Also, evenly space feeding times throughout the day, never feeding more than 8 pounds of concentrate per meal. 
 
During periods of hot weather (daily temperatures of 90 degrees or higher) and/or heavy sweating, mix 2 oz. of an 
electrolyte supplement into the horse's daily ration. 
Manufactured by 
PRODUCERS COOPERATIVE ASSOCIATION 
Bryan, Texas  77806 
 
Net Weight 50 lbs. (22.68 kg) or Bulk 
96  3  3/15/2013                    MFG: 
